Terug
Publications Van Creveldkliniek
Publications Van Creveldkliniek
Publications Van Creveldkliniek
Below you will find a selection of articles that were recently published by researchers of the Van Creveldkliniek. We have provided summaries in layman's language (Dutch and English) for your convenience.
- Bleeding control improves after switching to emicizumab: Real-world experience of 177 children in the PedNet registry
- One year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study (ESTIMATE study) (March 2024)
- A bispecific antibody approach for the potential prophylactic treatment of inherited bleeding disorders (February 2024)
- Type 1 VWD classification revisited - novel insights from combined analysis of the LoVIC and WiN studies (January 2024)
- Heavy menstrual bleeding in adolescents: incidence, diagnostics, and management practices in primary care (October 2023)
- How long does it take for a joint bleed to pass? (HOCUS POCUS study) (20 April 2023)
- Unnoticed joint bleeding in people with haemophilia (BEGIN study)(13 April 2023)
- Sports Participation, Injuries and Bleeds in People with Haemophilia (23 March 2023)
- Increase FIX-levels and decrease in number of bleeds in participants of the HOPE-B gene therapy study for haemophilia (16 March 2023)
- Pain while injecting emicizumab predominant in children, a report of Dutch experiences (15 February 2023)
- Interference in point-of-care international normalized ratio monitoring in patients with lupus anticoagulant is correlated with anti–β2-glycoprotein I antibody titers (10 February 2023)
- Hemophilia in Netherlands - 6 (09 January 2023)
- Menstrual problems in chronic immune thrombocytopenia: A monthly challenge - a cohort study and review (07 June 2022)
- Mitapivat versus placebo in pyruvate kinase deficiency (29 April 2022)
- Checklist Individual Strength to measure severe fatigue in immune thrombocytopenia (31 January 2022)
- Shortening the Haemophilia Activities List (HAL) and pediatric HAL (22 September 2021)
- Musculoskeletal ultrasound in hemophilia: Results and recommendations from a global survey and consensus meeting (19 July 2021)
- The Role of Physiotherapy in the New Treatment Landscape for Haemophilia (02 July 2021)
- Similar sports participation as the general population in Dutch persons with haemophilia; results from a nationwide study (21 June 2021)
- Lactate dehydrogenase to carboxyhemoglobin ratio as a biomarker of heme release to heme processing is associated with higher tricuspid regurgitant jet velocity and early death in sickle cell disease (08 June 2021)
- A proposed concept for defective mitophagy leading to late stage ineffective erythropoiesis in pyruvate kinase deficiency (18 February 2021)
- A unique monocyte transcriptome discriminates sickle cell disease from other hereditary hemolytic anemias and shows the particular importance of lipid and interferon signaling (18 February 2021)
- Sports participation is not associated with adherence to prophylaxis in Dutch patients with haemophilia (10 February 2021)
- Anti-β2-glycoprotein I and anti-prothrombin antibodies cause lupus anticoagulant through different mechanisms of action (02 February 2021)
- Biochemical marker research in hemophilic arthropathy: a systematic review (14 December 2020)
- Sports participation of patients with haemophilia in the COVID-19 era: The Dutch experience (11 November 2020)
- Evaluating international Haemophilia Joint Health Score (HJHS) results combined with expert opinion: Options for a shorter HJHS (29 October 2020)
- The experiences and attitudes of hemophilia carriers around pregnancy: A qualitative systematic review (27 October 2020)
Contact
Do you have any questions about one of our publications? Or do you want to get in touch with one of our researchers? Please feel free to contact the research team of the Van Creveldkliniek.
Telefoonnummer: +31 (0)88 75 584 50
Email adres: vck-research@umcutrecht.nl